Global Radioactive Therapeutic Drugs Supply, Demand and Key Producers, 2023-2029

Global Radioactive Therapeutic Drugs Supply, Demand and Key Producers, 2023-2029

The global Radioactive Therapeutic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.

This report studies the global Radioactive Therapeutic Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radioactive Therapeutic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioactive Therapeutic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Radioactive Therapeutic Drugs total market, 2018-2029, (USD Million)

Global Radioactive Therapeutic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Radioactive Therapeutic Drugs total market, key domestic companies and share, (USD Million)

Global Radioactive Therapeutic Drugs revenue by player and market share 2018-2023, (USD Million)

Global Radioactive Therapeutic Drugs total market by Type, CAGR, 2018-2029, (USD Million)

Global Radioactive Therapeutic Drugs total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Radioactive Therapeutic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radioactive Therapeutic Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Radioactive Therapeutic Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Radioactive Therapeutic Drugs Market, Segmentation by Type
Oncology
Cardiology
Others

Global Radioactive Therapeutic Drugs Market, Segmentation by Application
Hospitals
Academic & Research Institutes
Others

Companies Profiled:
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals

Key Questions Answered

1. How big is the global Radioactive Therapeutic Drugs market?

2. What is the demand of the global Radioactive Therapeutic Drugs market?

3. What is the year over year growth of the global Radioactive Therapeutic Drugs market?

4. What is the total value of the global Radioactive Therapeutic Drugs market?

5. Who are the major players in the global Radioactive Therapeutic Drugs market?